Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    Latest News, Synovial Sarcoma Registry

    Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository

    December 23, 2025 ayushis Comments Off on Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository
    A smiling woman with short dark hair and a black shirt takes a selfie. Text reads "Carrie Carpunky." The Synovial Sarcoma Foundation’s name and logo appear in the bottom left corner.

    We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome our 100th registrant. This achievement signifies the growing commitment to advancing research and improving treatment options for patients with synovial sarcoma.

    The registry serves as a pivotal resource, collecting invaluable data and biospecimens from patients diagnosed with synovial sarcoma. By participating, patients contribute to a collective effort to understand this rare form of cancer better and develop innovative treatment plans that can lead to improved outcomes. Every registration helps researchers in their mission to tailor therapies more effectively, offering hope to individuals and families affected by this challenging condition.

    Meet Carrie Carpunky: Our 100th Registrant

    Among the many courageous individuals contributing to this critical endeavor is Carrie Carpunky, our milestone registrant. Carrie’s journey with cancer began in 2010, when she experienced persistent stomach pains attributed initially to stress and a possible ulcer. It wasn’t until she consulted a gastrointestinal specialist that the word “tumor” entered her reality, launching her into a whirlwind of tests, emotions, and eventually, a cancer diagnosis.

    A collage of five photos featuring a woman with brown hair, sometimes with a man or a younger woman, in various settings including outdoors, smiling selfies, and with a yellow “10 Years Free” shirt and red mask.

    Carrie’s story is one of resilience. After a partial gastrectomy procedure, she found herself grappling with the ramifications of her diagnosis. Yet through the ups and downs of her journey—including a tumor that remained localized against the odds and the anguish of watching her symptoms evolve—she found an incredible ally in her oncologist, Dr. Brian VanTine, who provided care and compassion throughout her experience.

    Following years of diligent monitoring and treatment, Carrie has reached a point where she goes for annual check-ups, underscoring the value of early intervention and unwavering support. The recent loss of Dr. VanTine deeply affected her. “He was more than my oncologist; he was a friend,” Carrie reflects, highlighting the bond that forms between patients and their healthcare providers.

    Get Involved

    We invite anyone diagnosed with synovial sarcoma to join the Synovial Sarcoma Registry and contribute to this crucial research effort. By participating, you are not only helping us build a comprehensive resource for researchers but also becoming part of a community that believes in the potential for better treatments and outcomes.

    To learn more about registering and participating in this vital initiative, please visit our official page: Synovial Sarcoma Registry.

    As we celebrate this milestone with Carrie and all our registrants, we renew our commitment to gathering insights that could drive breakthroughs in understanding synovial sarcoma. Together, we can make significant strides towards better therapies and, ultimately, a brighter future for those affected by this disease.

    Read Carrie’s journey here, and explore more stories from other patients by visiting our Patient Stories section. Each story offers a powerful reminder of the resilience within this community and the impact of collective participation in advancing research.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (7)
    • Dr. Theodore Laetsch (3)
    • Education (11)
    • Healthcare (7)
    • Latest News (8)
    • Rare Cancer (4)
    • Rare Cancer Funding (1)
    • Research (16)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A doctor interacts with a transparent digital screen displaying a 3D heart model, medical icons, and health data, including a heart rate graph, in a futuristic medical setting.
      Primary Cardiac Synovial Sarcoma: A Rare and Challenging Diagnosis
    • A healthcare worker wearing a blue mask and scrubs with a stethoscope around their neck stands next to a digital illustration of a virus, symbolizing medical response to infectious diseases.
      Post-Surgical Complication in Synovial Sarcoma: Rare Case Highlights Pleural Aspergillosis Risk
    • A doctor in a white coat with a stethoscope holds a digital tablet displaying floating DNA double helix graphics, representing genetic research or medical technology.
      Rare Tumor Case Highlights Importance of Accurate Diagnosis in Sarcoma Care

    Tags

    Afami-cel biomarker testing biomarker testing synovial sarcoma BRAF mutated synovial sarcoma CHOP Clinical Trials clinical trials rare cancer fungal infection immunotherapy Infant Market Growth metastatic synovial sarcoma lung Monophasic Synovial Sarcoma new treatments for synovial sarcoma P300 Parotid Gland pediatric synovial sarcoma Prasterone Rare Cancer rare cancer clinical trials rare disease funding rare fungal infections in cancer patients rare pediatric cancer rare soft tissue sarcoma research soft tissue sarcoma testing solitary fibrous tumor SS18-SSX translocation STAT6 marker SFT Synovial Sarcoma synovial sarcoma case report synovial sarcoma clinical trials Synovial Sarcoma Foundation synovial sarcoma in children synovial sarcoma research synovial sarcoma symptoms synovial sarcoma treatment synovial sarcoma treatment market T-Cell Therapy targeted cancer therapy targeted therapies for sarcoma targeted therapy TECELRA UK’s Rare Cancers Bill webinar

    Related posts

    A stethoscope rests on an open medical chart with a pen nearby, symbolizing healthcare, diagnosis, and medical documentation.
    Development, Latest News

    Synovial Sarcoma Treatment Market Growth Reflects Expanding Research

    March 16, 2026 ayushis Comments Off on Synovial Sarcoma Treatment Market Growth Reflects Expanding Research

    Recent industry analyses suggest the synovial sarcoma treatment market is expected to grow steadily, with projections estimating a compound annual growth rate (CAGR) of approximately 7.9% from 2026 to 2033. While market reports focus on financial trends and market size, they also reflect increasing investment in rare cancer research, drug development pipelines, and emerging therapies. […]

    A wooden judge’s gavel with a gold band rests on top of a British flag, symbolizing law or justice in the United Kingdom.
    Latest News, Rare Cancer

    A Turning Point for Rare Cancers

    March 11, 2026 ayushis Comments Off on A Turning Point for Rare Cancers

    What the UK’s Rare Cancers Bill Means for the Synovial Sarcoma Community For decades, patients diagnosed with rare cancers have faced a structural disadvantage. Fewer treatment options. Fewer clinical trials. Less research funding. Now a new law in the United Kingdom aims to change that. The Rare Cancers Bill, introduced by Dr Scott Arthur MP, […]

    A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
    Healthcare, Research

    Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma

    March 3, 2026 ayushis Comments Off on Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma

    Synovial sarcoma is a rare and often aggressive cancer that can become difficult to treat once it spreads. Traditional chemotherapy options are limited, and outcomes for metastatic disease remain poor. New research is exploring whether advanced T-cell therapies may offer another option. A recent clinical trial evaluated afamitresgene autoleucel (afami-cel), an engineered T-cell therapy designed […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch